BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16511741)

  • 1. [Molecular pathogenesis of heart failure].
    Maier LS
    Dtsch Med Wochenschr; 2006 Mar; 131(10):503-5. PubMed ID: 16511741
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond beta blockers.
    Bers DM
    Nat Med; 2005 Apr; 11(4):379-80. PubMed ID: 15812516
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of heart failure and preserved systolic function].
    Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
    Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract]   [Full Text] [Related]  

  • 4. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenergic activation in heart failure: blockade or rebalance?].
    Emdin M; Vergaro G; Giannoni A; Passino C
    G Ital Cardiol (Rome); 2010 Mar; 11(3):229-32. PubMed ID: 20550063
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart failure.
    McKelvie R
    Clin Evid; 2006 Jun; (15):118-39. PubMed ID: 16973007
    [No Abstract]   [Full Text] [Related]  

  • 8. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
    Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic heart failure.
    Poole-Wilson PA
    Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E2. PubMed ID: 18297148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Muscular dystrophy associated with heart failure].
    Ogata H
    Nihon Rinsho; 2007 May; 65 Suppl 5():456-9. PubMed ID: 17571418
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diastolic heart failure -- a disease of the elderly].
    Witthaut R
    Dtsch Med Wochenschr; 2005 Mar; 130(12):704-9. PubMed ID: 15776355
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
    Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
    Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HF epidemic: the need for new treatment strategies.
    Carson PE
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S32-4. PubMed ID: 17199218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of RAS block in heart diseases].
    Saito Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1750-5. PubMed ID: 17037310
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic potential of functional selectivity in the treatment of heart failure.
    Christensen GL; Aplin M; Hansen JL
    Trends Cardiovasc Med; 2010 Oct; 20(7):221-7. PubMed ID: 22293022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal management of chronic heart failure in patients with chronic kidney disease.
    Zachariah D; Kalra PA; Kalra PR
    J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options].
    Boldt LH; Rolf S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2349-54. PubMed ID: 18958832
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in the treatment of heart failure with a preserved ejection fraction.
    Das A; Abraham S; Deswal A
    Curr Opin Cardiol; 2008 May; 23(3):233-40. PubMed ID: 18382212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combination angiotensin-converting enzyme and angiotensin receptor blocker therapy on heart failure mortality and morbidity.
    Kapoor JR
    Am J Cardiol; 2008 Mar; 101(5):744-5. PubMed ID: 18308033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.